SIRPA and neoplasm: For example, blockade of the phagocytosis checkpoint SIRPA, which binds to CD47 that is upregulated on tumor cells [204], has been shown to enhance myeloid cell-dependent killing of Burkitt’s lymphoma through antibody-dependent cellular phagocytosis in SRG mice [205].